USPTO serial 99424969
WELCOME TO YOUR NEW LIFE
Reviewed by CopyMark Law Group
Status 641Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- ANKRAH, NAAKWAMA S
- Law office
- TMEG LAW OFFICE 109
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with WELCOME TO YOUR NEW LIFE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Danielle Mattessich
Danielle Mattessich Merchant & Gould P.C.P.O. Box 2910150 South Fifth Street, Suite 2200Minneapolis, MN 55402Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling the distribution or use of electricity; Apparatus for recording, transmission or reproduction of sound or images; Battery modules; Electrical power supplies; Computer monitors; Computer display monitors; Mixing apparatus for medical and surgical purposes, namely, electronic gas-flow controllers and monitors for regulating mixtures of air, oxygen and carbon dioxide; Electronic control and regulating apparatus for regulating equipment and apparatus for medical and surgical purposes; Electronic control systems for machines used for medical and surgical purposes; Data processing apparatus; Computer hardware and recorded software sold as a unit for use with medical patient monitoring equipment, for receiving, processing, transmitting and displaying data; Downloadable computer software for tracking, monitoring and managing patient medical information; Downloadable mobile applications for assisting and improving the life of persons with medical conditions through tracking, monitoring and managing a user's medical condition, health activity, and lifestyle; Downloadable computer software for use in the diagnosis, monitoring, management, and treatment of obstructive sleep apnea; Downloadable application software for smartphones and mobile devices, namely, software for tracking and maintaining health and treatment plans related to sleep disorders; Downloadable software for facilitating communication and collaboration for medical treatment related to sleep disorders between medical facilities, clinicians, caregivers, and patients; Downloadable software for collecting, analyzing and organizing information related to sleep disorders; Software as a Medical Device (SaMD), downloadable, for diagnosing and treating sleep disorders; Downloadable software in the nature of patient management and support software for receiving, storing, tracking, managing, and analyzing patient medical information related to sleep disorders; Downloadable computer software for use in collecting, storing, and reporting patient data, therapy outcomes, and titration results related to obstructive sleep apnea therapy; Downloadable computer software for the collection, editing, organizing, modifying, book marking, transmission, storage, and sharing of data and information for use in treating obstructive sleep apnea; Downloadable computer software for programming, monitoring, regulating, controlling, analyzing, recording, transmitting, and managing data for implantable medical devices, pacemakers, defibrillators, neurostimulation devices, extracorporeal circulation systems, perfusion systems, heart-lung machines, and cardiopulmonary bypass procedures; Downloadable computer software for analyzing electrocardiographic (ECG) signals and patient physiological data; Downloadable scientific and medical data via the internet; Downloadable instruction manuals in the fields of cardiopulmonary and cardiac surgery, neuromodulation, and advanced circulatory support; Handheld remote control units for controlling an implantable pulse generator; Research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids | ACTIVE | — |
| 010 | Transfusion devices, namely, blood transfusion apparatus and autotransfusion apparatus for collecting, processing, washing, separating and reinfusing a patient's own blood; Fittings specially adapted blood transfusion apparatus and autotransfusion apparatus, namely, tubing connectors, tubing adapters, vacuum-extension lines, aspiration and anticoagulation lines, disposable blood-processing bowls, blood-collection reservoirs, blood-reinfusion bags and blood filters; Mounting brackets, equipment-support masts, infusion racks, console housings and pump housings, all specially adapted as structural parts and fittings for heart-lung machines and extracorporeal perfusion systems; Mounting brackets specially adapted for oxygenators, blood reservoirs, blood pumps, tubing clamps, control panels and medical sensors; Rack housings specially adapted for mounting and supporting components of heart-lung machines and extracorporeal perfusion systems; Cannulae; Extracorporeal carbon dioxide removal systems for medical use comprising medical device controllers, membrane gas exchangers, centrifugal blood pumps, dual-lumen venous catheters, blood and sweep-gas tubing, bacterial filters, blood-flow sensors, bubble detectors, and tubing connectors; Cardiopulmonary bypass (CBP) machines; Blood pumps for medical use in extracorporeal circulation systems, namely, roller blood pumps and centrifugal blood pumps; Circulatory assist devices, namely, arterial cannulae, venous cannulae, transseptal cannulae, and dual-lumen right-atrium-to-pulmonary-artery cannulae for use in temporary mechanical circulatory support and extracorporeal life-support procedures; Systems and components that monitor and sense body data streams, namely, implantable neurostimulators featuring physiological sensors for detecting and recording changes in heart rate and patient body position; Medical devices, namely, oxygenators; Suction instruments for surgery; Implantable medical pulse generators for neurostimulation; Implantable medical devices, namely, implantable neurostimulation systems comprising implantable programmable electrical pulse generators and implantable electrode leads for vagus nerve stimulation; Implantable medical devices, namely, implantable programmable electrical pulse generators for vagus nerve stimulation; Implantable medical devices, namely, implantable electrical leads and electrodes for vagus nerve stimulation; Implantable medical devices, namely, implantable vagus nerve stimulators; Implantable medical devices, namely, implantable electrodes for vagus nerve stimulation sold as components of implantable neurostimulation leads; Surgical implants comprising artificial material; Medical catheters and cannulae for extracorporeal circulation and cardiopulmonary bypass procedures, namely, arterial catheters and cannulae, venous-return catheters and cannulae, cardioplegia catheters and cannulae, transseptal cannulae, dual-lumen veno-venous cannulae, and flow-directed pulmonary-artery catheters for facilitating the placement of extracorporeal life-support cannulae; Patient medical monitors for monitoring heart rate and lung function; Medical patient-monitoring systems comprising patient monitors, in-line blood monitors, optical blood sensors, sensor modules and disposable sensor cuvettes for measuring, monitoring, displaying and recording arterial oxygen partial pressure, venous oxygen saturation, hematocrit, hemoglobin, blood temperature, blood pressure and blood flow during cardiopulmonary bypass procedures; Extracorporeal circulation apparatus for medical use, namely, heart-lung machines, roller and centrifugal blood pumps, blood-pump controllers, blood oxygenators, autotransfusion apparatus, hemoconcentrators, blood reservoirs, blood filters, perfusion tubing systems, and heater-cooler apparatus for controlling blood temperature during cardiopulmonary bypass procedures; Extracorporeal apparatus, namely, disposable integrated extracorporeal blood-circulation circuits comprised of oxygenators, blood reservoirs, tubing, connectors, filters, heat exchangers and bubble traps, for use with heart-lung machines; Extracorporeal apparatus, namely, blood-flow, blood-pressure and temperature regulators for extracorporeal circulation apparatus; Programmers, namely, portable electronic medical-device programming and telemetry systems comprising touchscreen medical-device programmers and wireless telemetry wands for programming, interrogating, testing and monitoring implantable vagus nerve stimulators; Electronic medical-device programmers and programming wands for programming, interrogating, testing and monitoring implantable vagus nerve stimulators; One-way check valves sold as integral components of cardioplegia cannulae; Electronic measuring apparatus for measuring blood flow, gas flow, pressure, temperature, oxygen partial pressure, oxygen saturation, hematocrit and hemoglobin in extracorporeal perfusion systems for medical and surgical purposes; Medical tubing for cardiopulmonary bypass, extracorporeal circulation, cardioplegia and autotransfusion procedures; Medical perfusion tubing systems comprising medical tubing, connectors, filters, blood reservoirs, clamps, stopcocks, heat exchangers and bubble traps for cardiopulmonary bypass and extracorporeal circulation; urgical instruments for implanting neurostimulation systems, namely, surgical tunnelers; vascular-access instruments, namely, cannula introducers and vascular dilators; Medical guidewires for inserting and positioning vascular cannulae; gas-exchange membranes sold as integral components of blood oxygenators; Filtration membranes sold as integral components of medical hemoconcentrators; Filters for medical purposes, namely, arterial blood filters for removing solid and gaseous emboli from extracorporeal blood circuits, gas-line filters for cardiopulmonary-bypass circuits, microaggregate filters for administering autologous blood and blood products, blood-collection filters for autotransfusion apparatus, and microporous hollow-fiber hemoconcentrators for extracorporeal blood filtration; Surgical tunnelers for implanting neurostimulation leads; Medical sensors and detectors for monitoring fluid levels and detecting air bubbles in extracorporeal blood circuits; Medical sensors and detectors for monitoring fluid levels and detecting air bubbles in extracorporeal blood circuits; Medical gas filters for cardiopulmonary-bypass circuits; Membrane oxygenators for oxygenating blood and removing carbon dioxide; blood-gas measuring and monitoring apparatus; arterial blood filters for removing gaseous emboli; pressure- and vacuum-relief valves for extracorporeal perfusion circuits; Consoles specially adapted for heart-lung machines and extracorporeal perfusion systems; Medical gas-flow regulators for regulating mixtures of air, oxygen and carbon dioxide supplied to blood oxygenators; Patient kits comprised primarily of medical magnets for activating, deactivating and testing implantable vagus nerve stimulators, and also including wristbands and belt clips specially adapted for carrying the medical magnets; Temporary circulatory-assist devices, namely, dual-lumen right-atrium-to-pulmonary-artery cannulae and transseptal cannulae for use with extracorporeal blood pumps; Medical blood-flow measurement systems comprising blood-flow sensors, sensor modules and medical monitors for measuring and displaying blood flow in extracorporeal blood circuits; Vascular devices, namely, arterial cannulae, venous cannulae, cardioplegia cannulae, transseptal cannulae, dual-lumen veno-venous cannulae, cannula introducers, vascular dilators and medical guidewires; Medical gas blenders; Controllers specially adapted for heart-lung machines, blood pumps and heater-cooler apparatus used during cardiopulmonary bypass procedures; Electronic venous-line occluders and electrically operated tubing clamps for controlling blood flow in extracorporeal blood circuits; Artificial heart-lung machines; Structural and replacement parts and fittings specially adapted for the foregoing medical apparatus and instruments | ACTIVE | — |
| 037 | Installation, maintenance and repair of surgical and medical apparatus, devices and instruments | ACTIVE | — |
| 042 | Design and development of computer hardware and software for use in the medical field; Medical research in the fields of cardiopulmonary and cardiac surgery, neuromodulation, epilepsy, advanced circulatory support, depression, and sleep disorders; Non-downloadable computer software for tracking, monitoring and managing patient medical information; Non-downloadable software for assisting and improving the life of persons with medical conditions through tracking, monitoring and managing a user's medical condition, health activity, and lifestyle; Non-downloadable computer software for use in the diagnosis, monitoring, management, and treatment of obstructive sleep apnea; Non-downloadable computer software for tracking and maintaining health and treatment plans related to sleep disorders; Non-downloadable software for facilitating communication and collaboration for medical treatment related to sleep disorders between medical facilities, clinicians, caregivers, and patients; Non-downloadable computer software for collecting, analyzing and organizing information related to sleep disorders; Non-downloadable computer software in the nature of patient management and support software for receiving, storing, tracking, managing, and analyzing patient medical information related to sleep disorders; Non-downloadable computer software for use in collecting, storing, and reporting patient data, therapy outcomes, and titration results related to obstructive sleep apnea therapy; Non-downloadable computer software for the collection, editing, organizing, modifying, book marking, transmission, storage, and sharing of data and information for use in treating obstructive sleep apnea; Non-downloadable computer software for programming, monitoring, regulating, controlling, analyzing, recording, transmitting, and managing data for implantable medical devices, pacemakers, defibrillators, neurostimulation devices, extracorporeal circulation systems, perfusion systems, heart-lung machines, and cardiopulmonary bypass procedures; Non-downloadable computer software for analyzing electrocardiographic (ECG) signals and patient physiological data; Scientific and technological services, namely, providing information about medical and scientific research in the fields of medical implants and associated medical therapies, product design and development in the field of medical implants; Scientific research and development in the medical and surgical fields | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by LIVANOVA PLC
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 037
- Other trademarks in Class 042
- Similar marks named WELCOME TO YOUR NEW LIFE
- Prosecution event GNRN explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 26, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 26, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 26, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 5, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 5, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 5, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 11, 2026 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| May 11, 2026 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Feb 10, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 10, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 10, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 5, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 2, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 2, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 2, 2025 | NWAP | NEW APPLICATION ENTERED | — |